Cancer statistics, 2016

Siegel, Rebecca L., Miller, Kimberly D., Jemal, Ahmedin·2016·CA: A Cancer Journal for Clinicians

Cited by (1,069)

Items 1,001–1,069 of 1,069

  1. Comparing Quality of Life in Breast Cancer Patients Who Underwent Mastectomy Versus Breast-Conserving Surgery: A Meta-Analysis
    Elvin T. Ng, Russell Z. Ang, Bach Xuan Tran, Cyrus S. H. Ho, Zhisong Zhang, Wanqiu Tan, Yu Bai, Min Zhang, Wilson Tam, Roger Ho · 2019 · International Journal of Environmental Research and Public Health
  2. Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
    Shira Yomtoubian, Sharrell B. Lee, Akanksha Verma, Franco Izzo, Geoffrey J. Markowitz, Hyejin Choi, Leandro C. A. Cerchietti, Linda T. Vahdat, Kristy A. Brown, Eleni Andreopoulou et al. · 2020 · Cell Reports
  3. Thymoquinone, as a Novel Therapeutic Candidate of Cancers
    Belal Almajali, Hamid Ali Nagi Al‐Jamal, Wan Rohani Wan Taib, Imilia Ismail, Muhammad Farid Johan, Abd Almonem Doolaanea, Wisam Nabeel Ibrahim · 2021 · Pharmaceuticals
  4. The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond
    Sullivan, Ryan, Maresh, Grace, Zhang, Xin, Salomon, Carlos, Hooper, John, Margolin, David, Li, Li · 2017 · Frontiers in Endocrinology
  5. Imaging γ-Glutamyltranspeptidase for tumor identification and resection guidance via enzyme-triggered fluorescent probe
    Li, Haidong, Yao, Qichao, Xu, Feng, Xu, Ning, Duan, Ran, Long, Saran, Fan, Jiangli, Du, Jianjun, Wang, Jingyun, Peng, Xiaojun · 2018 · Biomaterials
  6. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries
    Maher, Toby M., Molina-Molina, Maria, Russell, Anne-Marie, Bonella, Francesco, Jouneau, Stéphane, Ripamonti, Elena, Axmann, Judit, Vancheri, Carlo · 2017 · BMC Pulmonary Medicine
  7. Mitochondrial localization, import, and mitochondrial function of the androgen receptor
    Bajpai, Prachi, Koc, Emine, Sonpavde, Guru, Singh, Rajender, Singh, Keshav K. · 2019 · Journal of Biological Chemistry
  8. Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers
    de Oliveira, Graciele Almeida, Cheng, Robert Y.S., Ridnour, Lisa A., Basudhar, Debashree, Somasundaram, Veena, McVicar, Daniel W., Monteiro, Hugo Pequeno, Wink, David A. · 2017 · Antioxidants & Redox Signaling
  9. Thermo- and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo-photothermal therapy against subcutaneous and metastatic breast tumors
    Yang, Zhe, Cheng, Rui, Zhao, Chenyang, Sun, Na, Luo, Huiyan, Chen, Ya, Liu, Zerong, Li, Xian, Liu, Jie, Tian, Zhongmin · 2018 · Theranostics
  10. Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
    Gong, Meiling, Li, Yan, Ye, Xiaoping, Zhang, Linlin, Wang, Zhifang, Xu, Xiaowen, Shen, Yejing, Zheng, Cuixia · 2020 · Cell Communication and Signaling
  11. Psychosocial issues in patients with head and neck cancer: an updated review with a focus on clinical interventions
    Smith, Joshua D., Shuman, Andrew G., Riba, Michelle B. · 2017 · Current Psychiatry Reports
  12. Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review
    Rahib, Lola, Fleshman, Julie M., Matrisian, Lynn M., Berlin, Jordan D. · 2016 · JAMA Oncology
  13. Photoprotection in specific populations: Children and people of color
    Cestari, Tania, Buster, Kesha · 2017 · Journal of the American Academy of Dermatology
  14. A microfluidic platform for drug screening in a 3D cancer microenvironment
    Pandya, Hardik J., Dhingra, Karan, Prabhakar, Devbalaji, Chandrasekar, Vineethkrishna, Natarajan, Siva Kumar, Vasan, Anish S., Kulkarni, Ashish, Shafiee, Hadi · 2017 · Biosensors and Bioelectronics
  15. Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
    Strand, Matthew S., Krasnick, Bradley A., Pan, Hua, Zhang, Xiuli, Bi, Ye, Brooks, Candace, Wetzel, Christopher, Sankpal, Narendra, Fleming, Timothy, Goedegebuure, S. Peter et al. · 2019 · Oncotarget
  16. BET Bromodomain Proteins as Cancer Therapeutic Targets
    Shu, Shaokun, Polyak, Kornelia · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
  17. Safety of proteasome inhibitors for treatment of multiple myeloma
    Schlafer, Danielle, Shah, Katherine S., Panjic, Elyse Hall, Lonial, Sagar · 2016 · Expert Opinion on Drug Safety
  18. Evaluation of a Computer-Based Decision Aid for Promoting Informed Prostate Cancer Screening Decisions Among African American Men: iDecide
    Owens, Otis L., Felder, Tisha, Tavakoli, Abbas S., Revels, Asa A., Friedman, Daniela B., Hughes-Halbert, Chanita, Hébert, James R. · 2019 · American Journal of Health Promotion
  19. Body mass index and lung cancer risk in never smokers: A meta-analysis
    Zhu, Hongjun, Zhang, Shuanglin · 2018 · BMC Cancer
  20. The role of technology in melanoma screening and diagnosis
    Young, Albert T., Vora, Niki B., Cortez, Jose, Tam, Andrew, Yeniay, Yildiray, Afifi, Ladi, Yan, Di, Nosrati, Adi, Wong, Andrew, Johal, Arjun et al. · 2021 · Pigment Cell & Melanoma Research
  21. SREBP2 contributes to cisplatin resistance in ovarian cancer cells
    Zheng, Lei, Li, Li, Lu, Yun, Jiang, Fangfang, Yang, Xiu-An · 2018 · Experimental Biology and Medicine
  22. Pancreatic cancer in Lynch syndrome patients
    Bujanda, Luis, Herreros-Villanueva, Marta · 2017 · Journal of Cancer
  23. Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies
    Huang, Xiaoyi, Gao, Yisha, Zhi, Xiaosong, Ta, Na, Jiang, Hui, Zheng, Jianming · 2016 · Scientific Reports
  24. Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε
    Sviderskiy, Vladislav O., Blumenberg, Lili, Gorodetsky, Elizabeth, Karakousi, Triantafyllia R., Hirsh, Nicole, Alvarez, Samantha W., Terzi, Erdem M., Kaparos, Efiyenia, Whiten, Gabrielle C., Ssebyala, Shakirah et al. · 2020 · Molecular Cell
  25. ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism
    Peng, David H., Kundu, Samrat T., Fradette, Jared J., Diao, Lixia, Tong, Pan, Byers, Lauren A., Wang, Jing, Canales, Jaime Rodriguez, Villalobos, Pamela A., Mino, Barbara et al. · 2019 · Science Translational Medicine
  26. Creating an mHealth App for Colorectal Cancer Screening: User-Centered Design Approach
    Griffin, Lauren, Lee, Donghee, Jaisle, Alyssa, Carek, Peter, George, Thomas, Laber, Eric, Lok, Benjamin, Modave, François, Paskett, Electra, Krieger, Janice · 2019 · JMIR Human Factors
  27. In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
    Veluchamy, John P., Lopez-Lastra, Silvia, Spanholtz, Jan, Bohme, Fenna, Kok, Nina, Heideman, Daniëlle A. M., Verheul, Henk M. W., Di Santo, James P., de Gruijl, Tanja D., van der Vliet, Hans J. · 2017 · Frontiers in Immunology
  28. Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs
    Jiang, Juhong, Gu, Yingying, Liu, Jing, Wu, Ruibin, Fu, Lin, Zhao, Jin, Guan, Yubao · 2016 · Lung Cancer
  29. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
    Lu, Wei-Qun, Hu, Ying-Ying, Lin, Xiao-Ping, Fan, Wei · 2017 · Oncotarget
  30. The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer
    Johansen, Julia S., Calatayud, Dan, Albieri, Vanna, Schultz, Nicolai A., Dehlendorff, Christian, Werner, Jens, Jensen, Benny V., Pfeiffer, Per, Bojesen, Stig E., Giese, Nathalia et al. · 2016 · International Journal of Cancer
  31. Efficacy of exercise interventions in patients with acute leukemia: a meta-analysis
    Zhou, Yuan, Zhu, Jinjie, Gu, Zejuan, Yin, Xiangguang · 2016 · PLoS ONE
  32. Cognitive Behavioral Therapy for Insomnia, Mindfulness, and Yoga in Patients With Breast Cancer with Sleep Disturbance: A Literature Review
    Zeichner, Simon B, Zeichner, Rachel L, Gogineni, Keerthi, Shatil, Sharon, Ioachimescu, Octavian · 2017 · Breast Cancer Basic and Clinical Research
  33. Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells
    Momeny, Majid, Yousefi, Hassan, Eyvani, Haniyeh, Moghaddaskho, Farima, Salehi, Ali, Esmaeili, Fatemeh, Alishahi, Zivar, Barghi, Farinaz, Vaezijoze, Somaye, Shamsaiegahkani, Sahar et al. · 2018 · The International Journal of Biochemistry & Cell Biology
  34. Biodegradable polyester unimolecular systems as emerging materials for therapeutic applications
    Liu, Xuan, Fan, Xiaoshan, Jiang, Lu, Loh, Xian Jun, Wu, Yun-Long, Li, Zibiao · 2018 · Journal of Materials Chemistry B
  35. Broad Detection of Alterations Predicted to Confer Lack of Benefit from EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
    Rankin, Andrew, Klempner, Samuel J., Erlich, Rachel, Sun, James X., Grothey, Axel, Fakih, Marwan, George, Thomas J., Lee, Jeeyun, Ross, Jeffrey S., Stephens, Philip J. et al. · 2016 · The Oncologist
  36. Haemoglobin in pelvic fluid rescues fallopian tube epithelial cells from reactive oxygen species stress and apoptosis
    Huang, Hsuan‐Shun, Hsu, Che‐Fang, Chu, Sung‐Chao, Chen, Pao‐Chu, Ding, Dah‐Ching, Chang, Meng‐Ya, Chu, Tang‐Yuan · 2016 · The Journal of Pathology
  37. Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer
    Shaojun, Chen, Li, Hua, Haixin, Huang, Guisheng, Li · 2018 · Cancer Biology & Therapy
  38. Fluid shear stress enhances natural killer cell’s cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing
    Hu, Bing, Xin, Ying, Hu, Guanshuo, Li, Keming, Tan, Youhua · 2023 · APL Bioengineering
  39. Exercise for improving bone health in women treated for stages I–III breast cancer: a systematic review and meta-analyses
    Fornusek, Canan P., Kilbreath, Sharon L. · 2017 · Journal of Cancer Survivorship
  40. Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients
    Pérez-Ramírez, Cristina, Cañadas-Garre, Marisa, Alnatsha, Ahmed, Villar, Eduardo, Delgado, Juan Ramón, Faus-Dáder, María José, Calleja-Hernández, Miguel ÿngel · 2016 · Pharmacological Research
  41. Molecular mechanism of triple‑negative breast cancer‑associated BRCA1 and the identification of signaling pathways
    Qi, Feng, Qin, Wen‑Xing, Zang, Yuan‑Sheng · 2019 · Oncology Letters
  42. The effect of progressive muscle relaxation on cancer patients’ self-efficacy
    Noruzi zamenjani, Masoomeh, Masmouei, Behnam, Harorani, Mehdi, Ghafarzadegan, Rezvan, Davodabady, Fahimeh, Zahedi, Sima, Davodabady, Zakie · 2019 · Complementary Therapies in Clinical Practice
  43. A urologist’s perspective on prostate cancer imaging: past, present, and future
    George, Arvin K., Turkbey, Baris, Valayil, Subin G., Muthigi, Akhil, Mertan, Francesca, Kongnyuy, Michael, Pinto, Peter A. · 2016 · Abdominal Radiology
  44. IL-17A-producing T cells are associated with the progression of lung adenocarcinoma
    Bao, Zhang, Lu, Guohua, Cui, Dawei, Yao, Yinan, Yang, Guangdie, Zhou, Jianying · 2016 · Oncology Reports
  45. Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
    Chen, Haibo, Luo, Dingyuan, Zhang, Lin, Lin, Xiaofeng, Luo, Qiuyun, Yi, Hanjie, Wang, Jing, Yan, Xianglei, Li, Baoxia, Chen, Yuelei et al. · 2017 · Oncotarget
  46. ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption
    Li, Xin, Zhang, Kejing, Hu, Yu, Luo, Na · 2020 · Bioscience Reports
  47. Associations among physical symptoms, fear of cancer recurrence, and emotional well-being among Chinese American breast cancer survivors: a path model
    Cho, Dalnim, Chu, Qiao, Lu, Qian · 2018 · Supportive Care in Cancer
  48. PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation
    Davis, Thomas B., Yang, Mingli, Schell, Michael J., Wang, Heiman, Ma, Le, Pledger, W. Jack, Yeatman, Timothy J. · 2018 · Scientific Reports
  49. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
    Yu, Zhuo, Feng, Hai, Zhuo, Yunhui, Li, Man, Zhu, Xiaojun, Huang, Lingying, Zhang, Xin, Zhou, Zhenhua, Zheng, Chao, Jiang, Yun et al. · 2020 · Cellular Oncology
  50. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer
    Omolo, Bernard, Yang, Mingli, Lo, Fang Yin, Schell, Michael J., Austin, Sharon, Howard, Kellie, Madan, Anup, Yeatman, Timothy J. · 2016 · BMC Medical Genomics
  51. PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro
    Wu, Xiaowen, Yu, Jiayi, Yan, Junya, Dai, Jie, Si, Lu, Chi, Zhihong, Sheng, Xinan, Cui, Chuanliang, Ma, Meng, Tang, Huan et al. · 2018 · Cancer Biology & Therapy
  52. The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy
    Greene, Justin, Nguyen, Anna, Bagby, Stacey M., Jones, Gemma N., Tai, WM., Quackenbush, Kevin S., Schreiber, Anna, Messersmith, Wells A., Devaraj, Kalpana M., Blatchford, Patrick et al. · 2017 · Oncotarget
  53. SMAD4 Y353C promotes the progression of PDAC
    Wang, Zusen, Li, Yongxing, Zhan, Shixiong, Zhang, Lu, Zhang, Shun, Tang, Qian, Li, Miaomiao, Tan, Zhen, Liu, Shiguo, Xing, Xiaoming · 2019 · BMC Cancer
  54. Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers
    Kenner, Barbara J., Go, Vay Liang W., Chari, Suresh T., Goldberg, Ann E., Rothschild, Laura J. · 2017 · Pancreas
  55. Strategies to Improve Persistent Adherence in Colorectal Cancer Screening
    Kew, Guan Sen, Koh, Calvin Jianyi · 2020 · Gut and Liver
  56. SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
    Liu, Zelin, Wang, Qinghua, Zhai, Guanzhong, Ke, Shuai, Yu, Xi, Guo, Jia · 2022 · Cancer Cell International
  57. The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy
    Wang, Yuan, Hu, Guo-fang, Wang, Zhehai · 2017 · OncoTargets and Therapy
  58. IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM
    Bazarbachi, Abdul Hamid, Avet-Loiseau, Hervé, Szalat, Raphael, Samur, Anil Aktas, Hunter, Zachary, Shammas, Masood, Corre, Jill, Fulciniti, Mariateresa, Anderson, Kenneth C., Parmigiani, Giovanni et al. · 2021 · Blood
  59. Cancer-Related Fatigue in Post-Treatment Cancer Survivors: Theory-Based Development of a Web-Based Intervention
    Corbett, Teresa, Walsh, Jane C, Groarke, AnnMarie, Moss-Morris, Rona, Morrissey, Eimear, McGuire, Brian E · 2017 · JMIR Cancer
  60. Cancer Patients’ and Survivors’ Perceptions of the Calm App: Cross-Sectional Descriptive Study
    Huberty, Jennifer, Puzia, Megan, Eckert, Ryan, Larkey, Linda · 2020 · JMIR Cancer
  61. Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer
    Iovanna, Juan · 2021 · Translational Oncology
  62. A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
    Liu, Tong, Jiang, Shuai, Teng, Xue, Zhong, Lu, Liu, Mengmeng, Jin, Yao, Dong, Mei · 2023 · Immunopharmacology and Immunotoxicology
  63. Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models
    Chen, Chao-Yi, Yang, Yi-Feng, Wang, Paul C., Shan, Liang, Lin, Stephen, Chen, Po-Jung, Chen, Yi-Jung, Chiang, Han-Sun, Lin, Jaw-Town, Hung, Chi-Feng et al. · 2022 · Pharmaceuticals
  64. PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
    Davis, Thomas B., Yang, Mingli, Wang, Heiman, Lee, Changgong, Yeatman, Timothy J., Pledger, W. Jack · 2019 · Oncotarget
  65. Differentiation among prostate cancer patients with Gleason score of 7 using histopathology image and genomic data
    Qi, Xin, Karagoz, Kubra, Ren, Jian, Foran, David J., Gatza, Michael · 2018 · Medical Imaging 2018: Imaging Informatics for Healthcare, Research, and Applications
  66. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
    Liao, Tianyou, Lu, Yan, Li, Wangji, Wang, Kang, Zhang, Yanxiang, Luo, Zhentao, Ju, Yongle, Ouyang, Manzhao · 2022 · Frontiers in Genetics
  67. Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
    Dehghani, Mehdi, Samani, Zahra, Abidi, Hassan, Manzouri, Leila, Mahmoudi, Reza, Hosseini Teshnizi, Saeed, Nikseresht, Mohsen · 2018 · International Journal of Genomics
  68. Applying pre-participation exercise screening to breast cancer survivors: a cross-sectional study
    Igwebuike, Lotachukwu T., Zhang, Xiaochen, Brown, Justin C., Schmitz, Kathryn H. · 2018 · Supportive Care in Cancer
  69. PET/MRI in Brain Tumors
    Sonni, Ida, Garibotto, Valentina, Iagaru, Andrei, Das, Devsmita, Massoud, Tarik · 2018 · PET/MRI in Oncology